APPLIED DNA SCIENCES INC (APDN) Stock Balance Sheet
NASDAQ:APDN - Nasdaq - US03815U4094 - Common Stock - Currency: USD
| MRQ (2024-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 9.29M | 6.43M | 7.15M | 15.21M | 6.55M | |||
| Receivables | 911.50K | 362.01K | 256.00K | 3.07M | 2.80M | |||
| Inventories | 468.58K | 438.59K | 330.00K | 602.00K | 1.37M | |||
| Other Current Assets | 601.51K | 815.97K | 389.00K | 1.06M | 569.00K | |||
| Total Current Assets | 11.28M | 8.05M | 8.13M | 19.94M | 11.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.25M | 1.29M | 2.08M | 2.22M | 3.02M | |||
| Goodwill | N/A | N/A | N/A | N/A | 0.00 | |||
| Intangibles | 2.70M | 2.70M | 2.70M | N/A | 0.00 | |||
| Other Non-Current Assets | 750.00K | 750.00K | 750.00K | 99.00K | 95.00K | |||
| Total Non-Current Assets | 4.69M | 4.74M | 5.52M | 2.32M | 3.12M | |||
| TOTAL ASSETS | 15.97M | 12.79M | 13.65M | 22.27M | 14.42M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 935.63K | 1.17M | 1.70M | 1.88M | 981.00K | |||
| Accounts Payable | 1.23M | 1.17M | 1.07M | 1.74M | 2.01M | |||
| Other Current Liabilities | 217.22K | 58.79K | 76.00K | 564.00K | 281.00K | |||
| Total Current Liabilities | 2.39M | 2.40M | 2.85M | 4.18M | 3.27M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 684.12K | 684.12K | 684.00K | N/A | N/A | |||
| Other Non-Current Liabilities | 350.33K | 738.72K | 5.25M | 5.17M | 31.00K | |||
| Total Non-Current Liabilities | 830.61K | 1.25M | 5.86M | 5.17M | 31.00K | |||
| TOTAL LIABILITIES | 3.22M | 3.65M | 8.70M | 9.35M | 3.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -327.22M | -309.67M | -302.45M | -292.50M | -284.12M | |||
| Additional Paid In Capital | 339.92M | 318.81M | 307.38M | 305.40M | 295.23M | |||
| Minority Interest | -203.83K | -174.53K | -79.00K | -3.00K | -1.00K | |||
| Common Shares | 54.11K | 10.31K | 14.00K | 13.00K | 7.00K | |||
| Shares Outstanding | 54.11M | 10.31M | 683.00K | 645.00K | 374.00K | |||
| Tangible Book Value per Share | 0.19 | 0.62 | 3.30 | 20.02 | 29.72 | |||
| Total Shareholders' Equity | 12.75M | 9.14M | 4.95M | 12.91M | 11.11M | |||
| TOTAL LIABILITIES AND EQUITY | 15.97M | 12.79M | 13.65M | 22.27M | 14.42M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 4.72 | 3.36 | 2.86 | 4.77 | 3.45 | |||
| Return On Assets (ROA) | -147.70% | -56.50% | -72.86% | -37.63% | -99.09% | |||
| Return On Equity (ROE) | -184.96% | -79.03% | -200.91% | -64.89% | -128.54% | |||
All data in USD , ROIC based on taxRate of 0.21